Effect of Eluxadoline on Abdominal and Bowel Symptoms Over Time in Phase 3 Clinical Trials in Patients With Irritable Bowel Syndrome With Diarrhea

被引：1
|
作者：
Harris, Lucinda [1 ]
Lucak, Susan [2 ]
Chang, Lin [3 ]
Dove, Leonard S. [4 ]
Covington, Paul S. [5 ]
机构：
[1] Mayo Clin, Phoenix, AZ USA
[2] Columbia Univ, Med Ctr, New York, NY USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[4] Furiex Pharmaceut, Driftwood, TX USA
[5] Clin Dynamix, Wilmington, NC USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2015年 / 110卷
关键词：
D O I：
10.14309/00000434-201510001-01761
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1761
引用
收藏
页码：S748 / S748
页数：1
相关论文
共 50 条
  • [11] Eluxadoline Demonstrates Sustained Efficacy for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome in Phase 3 Clinical Trials
    Chey, William D.
    Dove, Scott
    Andrae, David
    Davenport, J. Michael
    Turner, Lisa
    Lopez, Rocio
    Covington, Paul S.
    GASTROENTEROLOGY, 2015, 148 (04) : S70 - S71
  • [12] Effects of Eluxadoline on a Range of Bowel and Abdominal Symptoms in Patients With Irritable Bowel Syndrome With Diarrhea who Report Inadequate Symptom Control With Loperamide
    Brenner, Darren M.
    Sayuk, Gregory S.
    Elmes, Steven J. R.
    Saeed, Mazen
    Chey, William D.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S273 - +
  • [13] Management of irritable bowel syndrome with diarrhea: focus on eluxadoline
    Jones, Jennifer
    Lembo, Anthony
    Heidelbaugh, Joel
    Kuritzky, Louis
    Lacy, Brian
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (04) : 567 - 578
  • [14] The place of eluxadoline in the management of irritable bowel syndrome with diarrhea
    Levio, Sherry
    Cash, Brooks D.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2017, 10 (09) : 715 - 725
  • [15] Safety and Efficacy of Eluxadoline in Female Patients with Irritable Bowel Syndrome with Diarrhea
    Lucak, Susan
    Halpert, Albena
    Morris, Charlene
    Riley, Laryl
    Dove, Leonard S.
    JOURNAL OF WOMENS HEALTH, 2016, 25 (04) : A22 - A22
  • [16] Clinical potential of eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome
    Sobolewska-Wlodarczyk, Aleksandra
    Wlodarczyk, Marcin
    Storr, Martin
    Fichna, Jakub
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 771 - 775
  • [17] Irritable Bowel Syndrome Eluxadoline as a new Option for the treatment of Diarrhea
    Franke, Katharina
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2016, 54 (04):
  • [18] Eluxadoline Demonstrates a Lack of Abuse Potential in Phase 2 and 3 Studies of Patients With Irritable Bowel Syndrome With Diarrhea
    Fant, Reginald V.
    Henningfield, Jack E.
    Cash, Brooks D.
    Dove, Leonard S.
    Covington, Paul S.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2017, 15 (07) : 1021 - +
  • [19] Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome
    Ozdener, Ayse Elif
    Rivkin, Anastasia
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 2827 - 2840
  • [20] Safety of Eluxadoline in Patients With Irritable Bowel Syndrome
    Croteau, Ryan
    Barkin, Jamie S.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 (10): : 1616 - 1616
12345